Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
THLD > SEC Filings for THLD > Form 8-K on 22-Oct-2013All Recent SEC Filings

Show all filings for THRESHOLD PHARMACEUTICALS INC

Form 8-K for THRESHOLD PHARMACEUTICALS INC


22-Oct-2013

Other Events


Item 8.01 Other Events.

On October 21, 2013, Threshold Pharmaceuticals, Inc. issued a press release regarding the announcement of early clinical data from two single-arm, open-label Phase 1 trials evaluating TH-302, an investigational, hypoxia-targeted drug, in combination with antiangiogenic agents for the treatment of advanced solid tumors.

The press release is attached as Exhibit 99.1 to this Form 8-K.

  Add THLD to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for THLD - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.